Thursday, 27 June 2013

Novartis' Omalizumab Meets Phase III Endpoints


Novartis reports new Phase III data showing omalizumab significantly...



http://www.pharmalive.com/novartis-omalizumab-meets-phase-iii-endpoints

No comments:

Post a Comment